Innovation

BCI Pharma is an innovative biopharmaceutical company focused on small molecule drug discovery.

Read more

We design innovative Kinase Inhibitors libraries and combine with our HTS platform/technology (Target and cell based assay) we identify Novel, Potent and Selective Kinase Inhibitor Hits which are further optimized to preclinical candidates.

Platform

A real Platform/Technology to deliver Novel, Potent and Selective Kinase Inhibitors.

Our goal

Our goal is to identify Potent and selective preclinical candidates to improve cancer, inflammation, neuroinflammation and pain treatments.

Collaboration

We can also collaborate on your kinase project under a Risk-sharing model.

News

BCI Pharma will attend Bio-europe, Hamburg, November 11th 2019

Let us introduce ourselves

A few words about us

BCI Pharma is an innovative biopharmaceutical company focused on small molecule drug discovery. We design innovative Kinase Inhibitors libraries and combine with our HTS platform/technology (Target and cell based assay) we identify Novel, Potent and Selective Kinase Inhibitor Hits which are further optimized to preclinical candidates.